Award
NIH Reporter #DA-059234-04S1
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Recipient
University of Colorado
Award Amount
$98,952.00
Ceiling
$98,952.00
Awarded
August 05, 2026
Identifier
DA-059234-04S1
NIH grant awarded to University of Colorado for a clinical trial studying hemp-derived cannabidiol as a treatment for cannabis use disorder in concentrate users.
Description
A placebo-controlled randomized trial comparing hemp-derived CBD with and without THC to assess reduction in THC use, cannabis use disorder symptoms, and withdrawal symptoms in 150 adult treatment-seeking cannabis concentrate users with DSM-5 cannabis use disorder over 8 weeks.